Identifying mortality risks in patients with opioid use disorder using brief screening assessment: Secondary mental health clinical records analysis. (1st July 2016)

• Record Type: Journal Article
• Authors: Bogdanowicz, Karolina Magda; Stewart, Robert; Chang, Chin-Kuo; Downs, Johnny; Khondoker, Mizanur; Shetty, Hitesh; Strang, John; Hayes, Richard Derek
• Is Part Of: Drug and alcohol dependence. Volume 164(2016)
• Page Start: 82
• Page End: 88
• Publication Date: 2016-07-01
• Subjects: Opioids -- Heroin -- Treatment -- Mortality -- Risk assessment -- Suicide -- Overdose -- Injecting; Drug abuse -- Periodicals; Alcoholism -- Periodicals; 616.86
• DOI: 10.1016/j.drugalcdep.2016.04.036
• Languages: English
• ISSNs: 0376-8716

Abstract

Highlights: Prompt identification of those at risk is key. We examine clinical appraisal of patient risks and mortality in 4488 opioid dependent patients. Addiction-specific risk assessment is useful in predicting mortality. Non-admission of patients where suicidality is evident increases mortality. Abstract: Background: Risk assessments are widely used, but their ability to predict outcomes in opioid use disorder (OUD) treatment remains unclear. Therefore, the aim was to investigate if addiction-specific brief risk screening is effective in identifying high mortality risk groups and if subsequent clinical actions following risk assessment impacts on mortality levels. Methods: Opioid use disorder (OUD) patients were identified in the South London and Maudsley Case Register. Deaths were identified through database linkage to the national mortality dataset. Cox and competing-risk regression were used to model associations between brief risk assessment domains and all-cause and overdose mortality in 4488 OUD patients, with up-to 6-year follow-up time where 227 deaths were registered. Data were stratified by admission to general mental health services. Results: All-cause mortality was significantly associated with unsafe injecting (HR 1.53, 95% CI 1.10–2.11) and clinically appraised likelihood of accidental overdose (HR 1.48, 95% CI 1.00–2.19). Overdose-mortality was significantly associated with unsafe injecting (SHR 2.52, 95% CI 1.11–5.70) and clinically appraised suicidality (SHR 2.89, 95% CI 1.38–6.03). Suicidality was associated with a twofold increase in mortality risk among OUD patients who were not admitted to mental health services within 2 months of their risk assessment (HR 2.03, 95% CI 1.67–3.24). Conclusions: Diagnosis-specific brief risk screening can identify OUD patient subgroups at increased risk of all-cause and overdose mortality. OUD patients, where suicidality is evident, who are not admitted into services are particularly vulnerable.